Cellular uptake of sepiapterin and tetrahydrobiopterin was compared quantitatively with RBL2H3 cells in culture. RBL2H3 is a mast cell line and has the ability to synthesize serotonin. Sepiapterin was incorporated and converted into tetrahydrobiopterin in the cell. The incorporation of sepiapterin was about 10 times faster than tetrahydrobiopterin. A low concentration of tetrahydrobiopterin was incorporated in a saturable manner up to about 10 J..LM, and it was superimposed upon a linearly concentration-dependent process. Overnight treatment with DAHP depleted endogenous tetrahydrobiopterin. The DAHP treated cells took up tetrahydrobiopterin faster than untreated cells.
Introduction
Tetrahydrobiopterin plays an essential role as cofactor of variety of hydroxylases or oxygen-linked enzymic reactions such as phenylalanine hydroxylase (1), tyrosine hydroxylase (2), tryptophan hydroxylase (3), glyceryl-ether mono-oxygenase (4), and NO-synthetase (5) . In case of newborn error in tetrahydrobiopterin metabolism which leads to insufficient supply of this compound, tetrahydrobiopterin therapy is unavoidable. It is well known, however, that incorporation of tetrahydrobiopterin into cells is not efficient when the compound must be supplied especially in the brain.
Tetrahydrobiopterin is synthesized from GTP via neopterin-triphosphate through tetrahydropterin compounds following of de novo pathway. Sepiapterin has been known to be incorporated and be converted to tetrahydrobiopterin, this pathway is now called a salvage pathway (6) . § Author to whom correspondence should be addressed.
Pteridines/ Vol. 7 / No. 4 In this report, incorporation of sepiapterin and tetrahydrobiopterin was compared using RBL2H3 cells in culture. The cells can synthesize. tetrahydrobiopterin and utilize it in its biosynthesis of serotonin as a cofactor of tryptophan hydroxylase.
Materials and Methods
Tetrahydrobiopterin was donated by Suntory Ltd. (Tokyo, Japan), sepiapterin was purchased from Schirks Laboratories (Jona, Switzerland). RBL2H3, a mast cell line derived from rat basophilic leukemia cells, was obtained from The Japanese Cancer Research Resources Bank (Tokyo, Japan). RBL2H3 cells were kept as a monolayer culture in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf serum. All cultures were maintained at 37"C under 5% CO 2 /95% air. For biopterin depletion experiments, cells were given 5 mM 2,4-diamino-6-hydroxypyrimidine (DAHP) overnight and through the experiment. Although tetrahydrobiopterin is rather stable under acid con-ditions, it is labile in neutral pH conditions. In the culture medium, the half-life was about 2 hours. Hence tetrahydrobiopterin was added in the culture medium with 1 mM DTI which allowed tetrahydrobiopterin to be stable for 2 hr at least. Determination of tetrahydrobiopterin in the cell was conducted essentially according to the method of Fukushin1a and Nixon (7). For routine work, however, acid oxidation was employed for measuring total biopterin. In brief, either tetrahydrobiopterin or sepiapterin was given to the culture and after the incubation, the cells were washed three times with Dulbecco's phosphate buffered saline (PBS), then HCI was added to the cells to bring it to 0.1 N, containing 1.2 ~M of pterin (a far larger amount than endogenous pterin) as an internal standard. I2/KI solution was added and the excessive iodine was reduced with ascorbic acid. For determination of tetrahydrobiopterin, pterin was measured after alkaline oxidation with I2/KI in 0.1 N NaOH without the internal standard. Biopterin and pterin were determined using an HPLC equipped with a fluorescence monitor (JASCO, Tokyo, Japan, FP-920) set 350 nm and 450 nm for excitation and emission, respectively. The solid phase used FineSIL C18-5T and the mobile phase used 7% methanol.
Results
In order to compare the incorporation of sepiapterin with that of tetrahydrobiopterin, 50 /J.M concentrations of these compounds were added to RBL2H3 cells in monolayer culture. The initial amount of cellular biopterin was, in a typical case, 108.8± 17.5 pmoljl0 6 cells. As shown in Fig. 1 , sepiapterin was incorporated and converted to biopterin linearly for at least 1 hours. The cellular biopterin amount after 1 hr incubation with 50 /J.M sepiapterin reached 4,125±287 pmoljl0 6 cells. A significant amount of biopterin was not detected when the samples were subjected to alkaline oxidation, indicating that the redox-state of cellular biopterin was mainly (>98%) in the tetrahydro-or quinonoid dihydro-form. On the other hand, the increase in biopterin in the presence of 50 /J.M tetrahydrobiopterin was only 475.3±46.6 pmoljl0 6 cells; this rise was about one tenth that of sepiapterin.
Sepiapterin is known to be converted into 7,8-dihydrobiopterin by the enzymatic action of sepiapterin reductase and then to tetrahydrobiopterin by diliydrofolate reductase (salvage pathway). The sepiapterin influx might not be encountered with its efflux because the incorporated sepiapterin is converted to dihydrobiopterin and hence the equilibrium between sepiapterin inside and outside is continuously advanced by the influx. In contrast, tetrahydrobiopterin uptake may be encountered to the efflux of tetrahydrobiopterin. In the latter case, intracellular concentration may reflect downward to the efficiency of the biopterin uptake. Thus we established biopterin-depleting conditions. Cells were exposed to 5 mM DAHP overnight and the intracellular biopterin con-centration decreased below the detection limit, whereas control cells (not-treated with DAHP) contained 41.4± 5 pmol of biopterin per 10 6 cells . When various concentrations of tetrahydrobiopterin were given to the DAHP-treated cells, the incorporation of tetrahydrobiopterin was significantly more efficient than that observed with the control cells at concentrations higher than 2-3 ~ (Fig. 2) . In both cases, with or without DAHP treatment, the concentration dependence seems to be related to the saturable process up to about 10 ~M and a process of linear-concentration dependence.
Discussion
In the early work by Fukushima (8) on biosynthetic pathways of biopterin from GTP, sepiapterin administered to tadpoles of Rana catesviana was demonstrated to dilute the radioactivity of biopterin derived from GTP-(U)-14C efficiently. This was interpreted to indicate that sepiapterin was an intermediate in biopterin biosynthesis and suggested that sepiapterin was efficiently taken up and merged into the metabolic pathway of biopterin. Based on the current knowledge regarding the biosynthesis of tetrahydrobiopterin, the above phenomenon was new evidence that the salvage pathway was functioning. Efficient uptake of sepiapterin by primary neuron culture of rat superior cervical ganglion and conversion to tetrahydrobiopterin was observed (Hasegawa and Kapatos, will be published elsewhere). In the present work, very efficient uptake of sepiapterin and conversion into tetrahydrobiopterin was demonstrated by use of RBL2H3 cells, a serotonin producing cell line. In high contrast, very inefficient uptake of tetrahydrobiopterin was also shown.
Administration of tetrahydrobiopterin to normal animals with regard to tetrahydrobiopterin metabolism hardly show significant stimulation in the catecholamine or serotonin biosynthesis although tetrahydrobiopterin level is sub-saturating. On the other hand, it is well known that tetrahydrobiopterin therapy in patients suffering from insufficient tetrahydrobiopterin can help dramatic improvement in monoamine biosynthesis, an indication of efficient uptake of extracellular tetrahydrobiopterin. The present results suggest that the cells incorporate tetrahydrobiopterin at low concentrations in a saturable manner which suggests some transporter-assisted process. Higher concentrations of tetrahydrobiopterin seemed to be in-corporated by diffusion. The fact that DAHP treated cells took up tetrahydrobiopterin to a greater extent may suggest an ability of the cell to attenuate the incorporation, depending on the intracellular concentration of the pterin. This experiment was performed after overnight exposure of the cells to 5 mM DAHP. Although no indication of cellular damage was observed, this treatment could have imposed certain modifications upon the cells causing increased membrane permeability.
In conclusion, sepiapterin incorporation by RBL2H3 cells was efficient, whereas tetrahydrobiopterin uptake was inefficient. Biopterin-deficient cells may take up tetrahydrobiopterin more efficiently than cells that already have an ordinary level of the pterin.
